Form 4: ASP Isotopes CEO Paul Mann Sells Shares Under 10b5-1 Trading Plan

ASP Isotopes CEO Paul Mann sold a total of 950,000 shares of common stock over three days, as disclosed in a Form 4 filing with the SEC.

Summary

• Paul Mann, CEO of ASP Isotopes Inc., sold shares of the company's common stock between April 15, 2025, and April 17, 2025.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2024.
• On April 15, 2025, 316,667 shares were sold at a weighted average price of $5.7535, with individual prices ranging from $5.48 to $6.70.
• On April 16, 2025, 316,667 shares were sold at a weighted average price of $5.4454, with individual prices ranging from $5.26 to $5.70.
• On April 17, 2025, 316,666 shares were sold at a weighted average price of $5.6213, with individual prices ranging from $5.25 to $6.02.
• Following these transactions, Paul Mann directly owns 7,315,454 shares of ASP Isotopes Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting insider trading activity. The sentiment is neutral as it simply reports facts without expressing any opinion or forward-looking statements.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.

Stakeholder Impact

• Shareholders may react to the news of the CEO's stock sales, although the existence of a 10b5-1 plan may mitigate concerns.
• The company itself may need to respond to investor inquiries regarding the sales.

Key Dates

Keywords

ASP Isotopes, Paul Mann, insider trading, Form 4, SEC filing, stock sale, Rule 10b5-1, ASPI